Clinical Trial Update: A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

Dose-expansion early-phase trial evaluating intravenous HNF4α srRNA for unresectable or metastatic colorectal cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HNF4α srRNA (HNF4α srRNA)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer Metastatic, Colorectal Cancer Recurrent | EARLY_Phase 1 | Status: RECRUITING